ÌìÃÀ´«Ã½

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
ÌìÃÀ´«Ã½ Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ÌìÃÀ´«Ã½ Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ÌìÃÀ´«Ã½ Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Potential role of N-benzylcinnamide in inducing neuronal differentiation from human amniotic fluid mesenchymal stem cells

7th Annual Global Pharma Summit

Wipawan Thangnipon, Nicha Puangmalai, Nirut Suwanna, Rungtip Soi-ampornkul, Ruchee Phonchai, Naiphinich Kotchabhakdi, Sujira Mukda, Tatsanee Phermthai, Suphakde Julavijitphong, Patoomratana Tuchinda and Saksit Nobsathian

Mahidol University, Thailand Kasetsart University, Thailand

Posters & Accepted Abstracts: Clin Pharmacol Biopharm

DOI:

Abstract
Neurodegenerative disorders are characterized by chronic and progressive loss of neurons in structure and function related to aging such as Alzheimerâ��s disease, the latter characterized by the degeneration of cholinergic neurons in basal forebrain connected to the cerebral cortex and hippocampus. Amniotic fluid mesenchymal stem cells (AF-MSCs) have been proposed as one of the candidates for stem cell therapy of nervous system disorders. This study demonstrate that incubation of AF-MSCs, obtained from 16-20 week pregnant women with 10 ng/ml bone morphogenetic protein (BMP)-9 for 48 hours in conditioned medium resulted in trans-differentiation to cholinergic neuronal-like cells. This phenomenon could also be obtained with N-benzylcinnamide (PT-3). Pre-treatment for 1 hour with 10 nM PT-3 augmented BMP-9 trans-differentiation effect, elevated �²III-tubulin cell numbers and fluorescence intensity of immunoreactive ChAT, ameliorated BMP-9-related production of reactive oxygen species and enhanced anti-apoptosis status of the neuronal-like cells. The trans-differentiation process was accompanied by increased p53 but decreased Notch1 and SIRT1 (p53 deacetylase) levels and activation of p38, ERK1/2 MAPK and PI3K/Akt pathways, in concert with inactivation of JNK, all of which were accentuated by PT-3 pre-treatment. These findings suggest that N-benzylcinnamide may not provide a useful adjuvant in BMP-9-induced trans-differentiation of AFMSCs into ultimately cholinergic neurons.
Biography

Email: wipawan.tha@mahidol.ac.th

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top